Therapeutic targets and functions of curcumol against COVID-19 and colon adenocarcinoma
Since 2019, the coronavirus disease (COVID-19) has caused 6,319,395 deaths worldwide. Although the COVID-19 vaccine is currently available, the latest variant of the virus, Omicron, spreads more easily than earlier strains, and its mortality rate is still high in patients with chronic diseases, espe...
Main Authors: | Jun Li, Peng Peng, Keng Po Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Nutrition |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2022.961697/full |
Similar Items
-
Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19
by: Lu Yang, et al.
Published: (2022-04-01) -
Curcumol inhibits encephalomyocarditis virus by promoting IFN-β secretion
by: Jiangang Zheng, et al.
Published: (2021-09-01) -
Curcumol inhibits proliferation and promotes apoptosis of human osteosarcoma cell lines
by: JIANG Ning, GUO Jun, LIU Cheng, ZHOU Ju
Published: (2022-08-01) -
Curcumol inhibits EMCV replication by activating CH25H and inhibiting the formation of ROs
by: Jiangang Zheng, et al.
Published: (2022-12-01) -
Curcumol Exerts Anticancer Effect in Cholangiocarcinoma Cells via Down-Regulating CDKL3
by: Jinduo Zhang, et al.
Published: (2018-03-01)